Characteristics of long-term glioblastoma survivors diagnosed from 2010 to 2016 in the United States

Author:

Ballard Christine Ann PittmanORCID,Wang Yubo,Kruchko Carol,Barnholtz-Sloan Jill S.ORCID,Li Yunqian,Ostrom Quinn T.ORCID

Funder

Sontag Foundation

American Brain Tumor Association

Novocure Ltd

National Brain Tumor Society

Uncle Kory Foundation

Musella Foundation For Brain Tumor Research and Information Inc

Pediatric Brain Tumor Foundation

National Institutes of Health National Cancer Institute

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Reference35 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States 2017-2021, Neuro Oncol;Price,2024

2. for the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and the National Cancer Institute of Canada Clinical Trials Group, Radiotherapy plus concomitant and adjuvant temozolomide for Glioblastoma;Stupp;N. Engl. J. Med.,2005

3. National Comprehensive Cancer Network, NCCN Guideline, 2025. https://www.nccn.org/guidelines/guidelines-detail?category= 1&id= 1425. (Accessed March 2025).

4. Beating the odds: extreme long-term survival with glioblastoma;Bi;Neuro Oncol.,2014

5. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;N. Engl. J. Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3